Stockscreener 앱 받기
4.32
4.64%
-0.21
Atea Pharmaceuticals Inc (AVIR) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Operating Expenses |
26.89%
35.10
|
48.01 | 54.93 | 45.57 | 41.34 |
| Depreciation and Amortization |
0.00%
0.104
|
0.104 | 0.104 | 0.104 | 0.104 |
| Operating Income/Loss |
26.89%
-35.10
|
-48.01 | -54.93 | -45.57 | -41.34 |
| Income/Loss From Continuing Operations Before Tax |
27.50%
-32.91
|
-45.39 | -51.63 | -41.85 | -36.95 |
| Income Tax Expense/Benefit |
52.00%
0.024
|
0.05 | -6.768 | 0.196 | 0.207 |
| Net Income/Loss |
27.52%
-32.93
|
-45.44 | -44.87 | -42.05 | -37.16 |
| Basic Average Shares |
1.08%
80.05
|
79.20 | -1.1285 | 79.05 | 83.75 |
| Diluted Average Shares |
1.08%
80.05
|
79.20 | -1.1285 | 79.05 | 83.75 |
| Basic Earnings Per Share |
28.07%
-0.41
|
-0.57 | -0.57 | -0.53 | -0.44 |
| Diluted Earnings Per Share |
28.07%
-0.41
|
-0.57 | -0.57 | -0.53 | -0.44 |
4.22%
자본화:
|
볼륨(24시간):